157 related articles for article (PubMed ID: 34397105)
41. Adherence to microsatellite instability testing in young-onset colorectal cancer patients.
Kessels K; Fidder HH; de Groot NL; Letteboer TG; Timmer R; van Dalen T; Consten EC; Offerhaus GJ; Siersema PD
Dis Colon Rectum; 2013 Jul; 56(7):825-33. PubMed ID: 23739188
[TBL] [Abstract][Full Text] [Related]
42. Analysis of DNA methylation-driven genes for predicting the prognosis of patients with colorectal cancer.
Fu B; Du C; Wu Z; Li M; Zhao Y; Liu X; Wu H; Wei M
Aging (Albany NY); 2020 Nov; 12(22):22814-22839. PubMed ID: 33203797
[TBL] [Abstract][Full Text] [Related]
43. Prognostic Significance of Autophagy-Relevant Gene Markers in Colorectal Cancer.
He Q; Li Z; Yin J; Li Y; Yin Y; Lei X; Zhu W
Front Oncol; 2021; 11():566539. PubMed ID: 33937013
[TBL] [Abstract][Full Text] [Related]
44. Epigenetic signatures of familial cancer are characteristic of tumor type and family category.
Joensuu EI; Abdel-Rahman WM; Ollikainen M; Ruosaari S; Knuutila S; Peltomäki P
Cancer Res; 2008 Jun; 68(12):4597-605. PubMed ID: 18559504
[TBL] [Abstract][Full Text] [Related]
45. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer.
Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y
Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035
[No Abstract] [Full Text] [Related]
46. Heterogeneity of DNA methylation status analyzed by bisulfite-PCR-SSCP and correlation with clinico-pathological characteristics in colorectal cancer.
Maekawa M; Sugano K; Ushiama M; Fukayama N; Nomoto K; Kashiwabara H; Fujita S; Kakizoe T
Clin Chem Lab Med; 2001 Feb; 39(2):121-8. PubMed ID: 11341745
[TBL] [Abstract][Full Text] [Related]
47. DNA methylation analysis using bisulfite treatment and PCR-single-strand conformation polymorphism in colorectal cancer showing microsatellite instability.
Maekawa M; Sugano K; Kashiwabara H; Ushiama M; Fujita S; Yoshimori M; Kakizoe T
Biochem Biophys Res Commun; 1999 Sep; 262(3):671-6. PubMed ID: 10471384
[TBL] [Abstract][Full Text] [Related]
48. Construction of Novel DNA Methylation-Based Prognostic Model to Predict Survival in Glioblastoma.
Zhao J; Wang L; Kong D; Hu G; Wei B
J Comput Biol; 2020 May; 27(5):718-728. PubMed ID: 31460783
[TBL] [Abstract][Full Text] [Related]
49. A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer.
Antelo M; Balaguer F; Shia J; Shen Y; Hur K; Moreira L; Cuatrecasas M; Bujanda L; Giraldez MD; Takahashi M; Cabanne A; Barugel ME; Arnold M; Roca EL; Andreu M; Castellvi-Bel S; Llor X; Jover R; Castells A; Boland CR; Goel A
PLoS One; 2012; 7(9):e45357. PubMed ID: 23049789
[TBL] [Abstract][Full Text] [Related]
50. Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenoma.
de Maat MF; Narita N; Benard A; Yoshimura T; Kuo C; Tollenaar RA; de Miranda NF; Turner RR; van de Velde CJ; Morreau H; Hoon DS
Am J Pathol; 2010 Nov; 177(5):2347-56. PubMed ID: 20952593
[TBL] [Abstract][Full Text] [Related]
51. Immune-related gene signature predicts overall survival of gastric cancer patients with varying microsatellite instability status.
Tian R; Hu J; Ma X; Liang L; Guo S
Aging (Albany NY); 2020 Dec; 13(2):2418-2435. PubMed ID: 33316777
[TBL] [Abstract][Full Text] [Related]
52. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
53. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
Zhou J; Wang X; Li Z; Jiang R
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
[TBL] [Abstract][Full Text] [Related]
54. Creation of a Prognostic Risk Prediction Model for Lung Adenocarcinoma Based on Gene Expression, Methylation, and Clinical Characteristics.
Ke H; Wu Y; Wang R; Wu X
Med Sci Monit; 2020 Oct; 26():e925833. PubMed ID: 33021972
[TBL] [Abstract][Full Text] [Related]
55. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
[TBL] [Abstract][Full Text] [Related]
56. Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients.
Rawson JB; Manno M; Mrkonjic M; Daftary D; Dicks E; Buchanan DD; Younghusband HB; Parfrey PS; Young JP; Pollett A; Green RC; Gallinger S; McLaughlin JR; Knight JA; Bapat B
Carcinogenesis; 2011 May; 32(5):741-7. PubMed ID: 21304055
[TBL] [Abstract][Full Text] [Related]
57. Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer.
Raedle J; Trojan J; Brieger A; Weber N; Schäfer D; Plotz G; Staib-Sebler E; Kriener S; Lorenz M; Zeuzem S
Ann Intern Med; 2001 Oct; 135(8 Pt 1):566-76. PubMed ID: 11601928
[TBL] [Abstract][Full Text] [Related]
58. Uncovering potential genes in colorectal cancer based on integrated and DNA methylation analysis in the gene expression omnibus database.
Wang G; Wang F; Meng Z; Wang N; Zhou C; Zhang J; Zhao L; Wang G; Shan B
BMC Cancer; 2022 Feb; 22(1):138. PubMed ID: 35114976
[TBL] [Abstract][Full Text] [Related]
59. Rate of dissemination and prognosis in early and advanced stage colorectal cancer based on microsatellite instability status: systematic review and meta-analysis.
Toh JWT; Phan K; Reza F; Chapuis P; Spring KJ
Int J Colorectal Dis; 2021 Aug; 36(8):1573-1596. PubMed ID: 33604737
[TBL] [Abstract][Full Text] [Related]
60. Integrative Analysis of Identifying Methylation-Driven Genes Signature Predicts Prognosis in Colorectal Carcinoma.
Huang H; Fu J; Zhang L; Xu J; Li D; Onwuka JU; Zhang D; Zhao L; Sun S; Zhu L; Zheng T; Jia C; Cui B; Zhao Y
Front Oncol; 2021; 11():629860. PubMed ID: 34178621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
